Lupus Treatment Report

www.LupusTreatmentReport.com

Pending

  • Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia.
  • The role of TASL in the pathogenesis of SLE: X marks the spot.
  • SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus.
  • The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine.
  • Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis.
  • Gilbert syndrome with systemic lupus erythematosus presenting with persistent unconjugated hyperbilirubinemia: A case report.
  • Cellulitis with Pseudomonas putida bacteremia in a patient with systemic lupus erythematosus: A case report.
  • Predictive factors of the lupus nephritis in a Tunisian cohort.
  • High prevalence of acquired thrombophilia without prognosis value in Covid-19 patients.
  • Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus.
  • A case of eosinophilic fasciitis without skin manifestations: a case report in a patient with lupus and literature review.
  • Analysis of time course and dose effect of tacrolimus on proteinuria in lupus nephritis patients.
  • Diagnostic and prognostic markers and treatment of connective tissue disease-associated pulmonary arterial hypertension: current recommendations and recent advances.
  • Response to: “A combination of complement activation products with autoantibodies predicts transition of probable lupus to systemic lupus erythematosus”.
  • Identifying novel B-cell targets for chronic inflammatory autoimmune disease by screening of chemical probes in a patient-derived cell assay.
  • Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
  • Sources of Pathogenic Nucleic Acids in Systemic Lupus Erythematosus.
  • Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans.
  • Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
  • Rowell’s syndrome: a rare but distinct entity in rheumatology.
  • StatPearls
  • StatPearls
  • Dirofilaria immitis in wolves recolonizing northern Italy: are wolves competent hosts?
  • Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
  • Correction: Clinical characteristics of systemic lupus erythematosus patients in long-term remission without treatment.
  • Images in Vascular Medicine. Marjolin’s ulcer with concurrent systemic lupus and venous disease.
  • Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: A systematic review and meta-analysis.
  • Biologics targeting type I interferons in SLE: A meta-analysis and systematic review of randomised controlled trials.
  • Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
  • Systematic Review: Monoclonal Antibody-Induced Subacute Cutaneous Lupus Erythematosus.
  • Invasive maxillary aspergillosis in a patient with systemic lupus erythematosus: Case report.
  • Expressions of IFN-γ and IL-4 before and after Treatment of Lupus Nephritis with Traditional Chinese Medicine Combined with Cyclophosphamide and Their Values for Efficacy Prediction and Evaluation.
  • Bortezomib at therapeutic doses poorly passes the blood-brain barrier and does not impair cognition.
  • Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.
  • Hepatic Infarction Caused by Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus.
  • Renal amyloidosis in a patient with systemic lupus erythematosus.
  • Long-Term Outcomes of Renal Transplant in Patients With End-Stage Renal Failure Due to Systemic Lupus Erythematosus and Granulomatosis With Polyangiitis.
  • COVID-19 Pandemic – A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
  • Facial erythema after the treatment of dupilumab in SLE patient.
  • Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus.
  • Evaluation of the inhibitory effect of tacrolimus combined with mycophenolate mofetil on mesangial cell proliferation based on the cell cycle.
  • High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
  • Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome.
  • De novo subacute cutaneous lupus erythematosus like eruptions in the setting of PD-1 or PD-L1 inhibitor therapy: clinical-pathological correlation.
  • Peripheral blood circular RNA hsa_circ_0082688-hsa_circ_0008675 can be used as a candidate biomarker of systemic lupus erythematosus with renal involvement.
  • Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion.
  • The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis.
  • Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis.
  • Hydroxychloroquine and coronavirus disease 19.
  • Cerebral Microhemorrhage and Purpuric Rash in COVID-19: The Case for a Secondary Microangiopathy.
  • A novel monoclonal antibody against human B7-1 protects against chronic graft-vs.-host disease in a murine lupus nephritis model.
  • PD-1 Inhibitor Therapy in a Patient with Preexisting P-ANCA Vasculitis: A Case Report and Review of the Literature.
  • Post-procedural Bacillus cereus septic arthritis in a patient with systemic lupus erythematosus.
  • Chloroquine to fight COVID-19: A consideration of mechanisms and adverse effects?
  • The Impact of Psychiatric Diagnosis and Treatment on Medication Adherence in Youth with Systemic Lupus Erythematosus.
  • Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
  • Belimumab as Add-on Therapy in Lupus Nephritis.
  • Medical conditions, pregnancy perspectives and contraceptive decision-making among young people: an exploratory, qualitative analysis.
  • An objective method of diagnosing hydroxychloroquine maculopathy.
  • Extracellular vesicles in Inflammatory Skin Disorders: from Pathophysiology to Treatment.
  • Antiphospholipid Antibodies Are Not Associated with Clinical Parameters or Prognostic Outcomes in Patients with Non-Hodgkin’s Lymphoma.
  • Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.
  • Management of cardiovascular disease in patients with systemic lupus erythematosus.
  • Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients.
  • Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies.
  • Unilateral facial erythematous patch as the presenting sign of systemic lupus erythematosus.
  • Genotype-Guided Hydralazine Therapy.
  • B cells polarize pathogenic inflammatory T helper subsets through ICOSL-dependent glycolysis.
  • Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus.
  • Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders.
  • IL-17 sustains the plasma cell response via p38-mediated Bcl-xL RNA stability in lupus pathogenesis.
  • Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus.
  • COPA syndrome, 5 years after: where are we?
  • Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus.
  • Editorial Comment to Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus.
  • [Antiphospholipid syndrome : Update on diagnostics and management].
  • Severe pulmonary arterial hypertension and interstitial pneumonia related to systemic lupus erythematosus successfully treated with mycophenolate mofetil: A novel case report.
  • Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout Gestation.
  • Modified Zhibai Dihuang pill, a traditional Chinese medicine formula, on steroid withdrawal in systemic lupus erythematosus: A systematic review and meta-analysis.
  • Autoantibody-dependent amplification of inflammation in SLE.
  • Modulation of cardiometabolic disease markers by type I interferon inhibition in systemic lupus erythematosus.
  • Efficacy of a sequential treatment by belimumab in monogenic systemic lupus erythematosus.
  • Efficacy and safety of sirolimus in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
  • New biomarkers in SLE: from bench to bedside.
  • The BAFF / APRIL system as therapeutic target in multiple sclerosis.
  • Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis.
  • Snare salvage technique for deformed WEB device after deployment.
  • Pregnancy in systemic lupus erythematosus.
  • Immunomodulatory Drugs in the Management of SARS-CoV-2.
  • Bilateral simultaneous Central Retinal Artery Occlusion (CRAO) in a patient with Systemic Lupus Erythematosus (SLE).
  • Serum IgG2 levels predict long-term protection following pneumococcal vaccination in systemic lupus erythematosus (SLE).
  • Immune-related adverse events in patients with solid-organ tumours treated with immunotherapy: a 3-year study of 102 cases from a single centre.
  • Epilepsy in systemic lupus erythematosus.
  • Inhibition of IRF5 hyper-activation protects from lupus onset and severity.
  • Terbinafine-induced lichenoid drug eruption: case report and review of terbinafine-associated cutaneous adverse events.
  • How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome.
  • Extracellular vesicles and lupus nephritis – New insights into pathophysiology and clinical implications.
  • Infection-related glomerulonephritis mimicking lupus nephritis.
  • Incidence, Clinical Features, and Outcomes of Late-onset Neutropenia from Rituximab for Autoimmune Disease.
  • Biologic therapies for systemic lupus erythematosus: where are we now?
  • Update on antimalarials and systemic lupus erythematosus.
  • Sixteenth international congress on antiphospholipid antibodies task force. Report on obstetric antiphospholipid syndrome.
  • Catch the rainbow: Prognostic factor of sarcoidosis.
  • New insights into the role of antinuclear antibodies in systemic lupus erythematosus.
  • Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19.
  • The Association Between Oral Health and Skin Disease.
  • A Study on the Relevance of Glucose-6-Phosphate Dehydrogenase Level Screening in Patients with Rheumatic Diseases Prior to Initiating Treatment With Hydroxychloroquine.
  • Systemic lupus erythematosus presenting as thrombotic thrombocytopaenic purpura in a child: a diagnostic challenge.
  • Clinical analysis of 4 cases of Wernekink commissure syndrome.
  • Stercoral Perforation of Sigmoid Colon in Systemic Lupus Erythematosus: A Rare Cause of Peritonitis.
  • Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis.
  • Mycophenolate mofetil in the treatment of Chinese patients with lupus nephritis: A PRISMA-compliant meta-analysis.
  • Primary breast diffuse large B-cell lymphoma in a patient with systemic lupus erythematosus: A case report and review of the literature.
  • TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases.
  • Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I interferon gene signature.
  • Rituximab in Treatment of Children with Refractory Vasculitis and Systemic Lupus Erythematosus – Single Center Experience in Croatia.
  • [Autoimmune hemolytic anemias].
  • [Hip osteonecrosis].
  • Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases.
  • A 31-Year-Old Man with COVID-19-Associated Empyema and Lupus Anticoagulant.
  • Complement Properdin Determines Disease Activity in MRL/lpr Mice.
  • Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Treatment.
  • Steroid treatment promotes an M2 anti-inflammatory macrophage phenotype in childhood lupus nephritis.
  • Clinical characteristics of systemic lupus erythematosus patients in long-term remission without treatment.
  • Essential role and therapeutic targeting of the glomerular endothelial glycocalyx in lupus nephritis.
  • Establishing Consensus Understanding of the Barriers to Drug Development in Lupus.
  • Case report: a 10-year-old girl with primary hypoparathyroidism and systemic lupus erythematosus.
  • Increased levels of plasma nucleotides in patients with rheumatoid arthritis.
  • Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective study.
  • Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’ by Mathian et al.
  • Comment on ‘Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19’ by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France.
  • Pharmacokinetics and pharmacodynamics of cenerimod, a selective S1P1 R modulator, are not affected by ethnicity in healthy Asian and Caucasian subjects.
  • Physical activity, sedentary behaviour and their associations with cardiovascular risk in systemic lupus erythematosus.
  • Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate.
  • The multi-targets mechanism of hydroxychloroquine in the treatment of systemic lupus erythematosus based on network pharmacology.
  • Mycophenolic acid area under the concentration-time curve is associated with therapeutic response in childhood-onset lupus nephritis.
  • Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview.
  • Cast-like calcification in the superior vena cava in a young woman with lupus nephritis on hemodialysis.
  • Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice.
  • Lupus Nephritis: Breaking the Lull.
  • Lupus Nephritis: How Far Have We Come, and Where Are We Headed?
  • Lupus Nephritis and Kidney Transplantation: Where Are We Today?
  • Bullous lupus as the first manifestation of systemic lupus erythematosus in the pediatric population: A diagnostic challenge in daily practice.
  • [Transverse myelitis syndrom as a result of neuromyelitis optica spectrum disorders, systemic lupus erythematosus and myasthenia gravis combination].
  • An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice.
  • Lupus Vasculitis.
  • Tripterygium and its plant extraction for systemic lupus erythematosus: A protocol for systematic review and meta analysis.
  • The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
  • Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.
  • Association of microRNA 17 host gene variant (rs4284505) with susceptibility and severity of systemic lupus erythematosus.
  • Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.
  • Severe systemic lupus erythematosus flare after abatacept treatment.
  • Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine.
  • The risk of hospitalized infection in patients with systemic lupus erythematosus treated with hydroxychloroquine.
  • Glucocorticoids in Systemic Lupus Erythematosus. Ten Questions and Some Issues.
  • Hydroxychloroquine is protective to the heart, not Harmful: A systematic review.
  • Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab: a case report.
  • Systemic Lupus Erythematosus: Targeted literature review of the epidemiology, current treatment and disease burden in the Asia Pacific region.
  • COVID-19 versus HIT hypercoagulability.
  • Stereochemical Differences in Fluorocyclopropyl Amides Enable Tuning of Btk Inhibition and Off-Target Activity.
  • The first case of natalizumab-induced subacute cutaenous lupus erythematosus.
  • [Update on treatments and innovations in systemic auto-immune diseases].
  • Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
  • EBV-positive mucocutaneous ulcer in a patient with systemic lupus erythematosus.
  • Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells.
  • Refractory lupus panniculitis treated successfully with rituximab: Two cases.
  • An Unusual and Rare Case of a Seronegative Male Patient With Lupus Nephritis.
  • Cutaneous squamous cell carcinoma as a complication of discoid lupus erythematosus.
  • Volunteer based approach to dog vaccination campaigns to eliminate human rabies: Lessons from Laikipia County, Kenya.
  • Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology.
  • Anifrolumab, a Monoclonal Antibody to the Type I Interferon Receptor Subunit 1, for the Treatment of Systemic Lupus Erythematosus: An Overview From Clinical Trials.
  • Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature.
  • Lower CH50 as a predictor for intractable or recurrent lupus enteritis: A retrospective observational study.
  • An unusual neurological presentation: systemic lupus erythematosus mimicking central nervous system infection.
  • Bio-inspired adhesive porous particles with human MSCs encapsulation for systemic lupus erythematosus treatment.
  • Disease-associated and patient-specific immune cell signatures in juvenile-onset systemic lupus erythematosus: patient stratification using a machine-learning approach.
  • Accelerated, severe lupus nephritis benefits from treatment with honokiol by immunoregulation and differentially regulating NF-κB/NLRP3 inflammasome and sirtuin 1/autophagy axis.
  • Cytomegalovirus preventive strategies in lupus nephritis and renal vasculitis treated with immunosuppressants.
  • Type B insulin resistance syndrome: a systematic review.
  • Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change.
  • Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis.
  • Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
  • Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study.
  • Belimumab, a useful alternative therapy in systemic lupus erythematosus serositis.
  • Microarray-based transcriptional profiling of a mouse model of autoimmune hepatitis.
  • Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis.
  • Orbital myositis in systemic lupus erythematosus: A case report and literature review.
  • A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases.
  • Recombinant Zoster Vaccine in Stable SLE Patients
  • Cervical Cancer Screening in Women with Systemic Lupus Erythematosus.
  • Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study.
  • [Hydroxychloroquine treatment rarely causes eye damage when used correctly].
  • CircZNF609 is involved in the pathogenesis of focal segmental glomerulosclerosis by sponging miR-615-5p.
  • Fertility preservation in women for medical and social reasons: Oocytes vs ovarian tissue.
  • Arterial Hypertension in Systemic Lupus Erythematosus: About 40 Cases.
  • Macrophage activation syndrome triggered by active systemic lupus erythematosus : Successful treatment by interleukin-1 inhibition (anakinra).
  • Treatment of Cutaneous Lupus Erythematosus With 1064-nm Neodymium-Doped Yttrium Aluminum Garnet Laser Verses Topical Corticosteroid Alone.
  • Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study.
  • Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.
  • Lupus low disease activity (SLE) in patients treated with belimumab: a single-center real-life experience (2016-2019).
  • Cutaneous lupus erythematosus induced by radiotherapy for breast carcinoma.
  • Evaluation of belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: Results from a 24-month OBSErve study in Argentina.
  • Vertical gaze palsy and intraoral numbness in a patient with neuro-psychiatric systemic lupus erythematosus: A case report and literature review.
  • Identification of critical genes in gastric cancer to predict prognosis using bioinformatics analysis methods.
  • IFN- γ and TNF- α drive a CXCL10 + CCL2 + macrophage phenotype expanded in severe COVID-19 and other diseases with tissue inflammation.
  • Serum syndecan-1, hyaluronan and thrombomodulin levels in patients with lupus nephritis.
  • Vitamin D status in a monocentric cohort of systemic lupus erythematosus (SLE) patients and correlations with clinical and immunological profile.
  • Coronary artery bypass graft surgery in a young female with systemic lupus erythematosus and its operative challenges: A case report.
  • Periocular discoid lupus erythematosus: diagnostic challenges of a clinical and histopathological masquerader.
  • Rapid Assembly and Screening of Multivalent Immune Cell-Redirecting Therapies for Leukemia.
  • Progressive multifocal leukoencephalopathy and sarcoidosis under interleukin 7: The price of healing.
  • Therapeutic Plasma Exchange Improved Pregnancy-associated Thrombotic Microangiopathy but not the Pregnancy Outcome in Patient with Systemic Lupus Erythematosus.
  • A review of advances in the understanding of lupus nephritis pathogenesis as a basis for emerging therapies.
  • Cardiovascular Considerations of Experimental Hydroxychloroquine Therapy on Patients Diagnosed With COVID-19: A Case Series Review.
  • Very Late-Onset Systemic Lupus Erythematosus as Unusual Cause of Reversible Functional and Cognitive Impairments in an Octogenarian Patient.
  • Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties.
  • Extrahepatic autoimmune diseases in primary biliary cholangitis: prevalence, significance for clinical presentation and disease outcome.
  • Potential five-mRNA signature model for the prediction of prognosis in patients with papillary thyroid carcinoma.
  • Vitiligo-like depigmentation subsequent to subacute cutaneous lupus erythematosus and hydroxychloroquine treatment.
  • Effects of BAFF neutralization on atherosclerosis associated with systemic lupus erythematosus.
  • Pickles and warfarin interaction: a case-based review.
  • Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
  • Children with chronic-refractory autoimmune cytopenias: a single center experience.
  • MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets.
  • Influence of total western diet on docosahexaenoic acid suppression of silica-triggered lupus flaring in NZBWF1 mice.
  • Differential approach to peripheral blood cell ratios in patients with systemic lupus erythematosus and various manifestations.
  • Soluble IL-2 Receptor in Dermatomyositis: Its Associations with Skin Ulcers and Disease Activity.
  • Cricoarytenoid joint arthritis: a possible complication of dermatomyositis.
  • Clinical Features and Outcomes of Bilateral Atypical Femoral Fractures.
  • An evidence based approach to refractory cutaneous lupus erythematosus.
  • Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations.
  • Mechanism of Follicular Helper T Cell Differentiation Regulated by Transcription Factors.
  • Risk of systemic lupus erythematosus in patients with endometriosis: A nationwide population-based cohort study.
  • [Proximal myopathy and fulminant heart failure in a 57 year-old female patient with lupus erythematosus].
  • Tumour necrosis factor inhibitor-induced myositis in a patient with ulcerative colitis.
  • Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: A systematic review.
  • Cosmetic camouflage improves health-related quality of life in women with systemic lupus erythematosus and permanent skin damage: A controlled intervention study.
  • Response to: ‘Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis’ by Singer et al.
  • Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus.
  • [Lupus anticoagulant-hypoprothrombinemia syndrome associated with follicular lymphoma].
  • Jieduquyuziyin Prescription Suppresses Inflammatory Activity of MRL/lpr Mice and Their Bone Marrow-Derived Macrophages via Inhibiting Expression of IRAK1-NF-κB Signaling Pathway.
  • Ureteric implantation into the bowel portion of augmented bladders during kidney transplantation: a review of urological complications and outcomes.
  • Activin-A in the regulation of immunity in health and disease.
  • Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases.
  • Systemic lupus erythematosus: an expert insight into emerging therapy agents in preclinical and early clinical development.
  • Cardiovascular System Affection and Its Relation to First-Year Mortality in Patients Initiating Maintenance Hemodialysis.
  • Expression Pattern of Telomerase Reverse Transcriptase (hTERT) Variants and Bcl-2 in Peripheral Lymphocytes of Systemic Lupus Erythematosus Patients.
  • Prevention of Infection in the Perioperative Setting in Patients with Rheumatic Disease Treated with Immunosuppression.
  • Acute severe sensory ganglionopathy in systemic lupus erythematous.
  • Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: ‘Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus’ by Chatzidionysiou et al.
  • Response to: ‘Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: ‘Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus’ by Chatzidionysiou et al’ by Bettiol et al.
  • Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway.
  • CALIBRATE: A Phase 2 Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
  • NEW INSIGHTS INTO THE PROGRESSION FROM CUTANEOUS LUPUS TO SYSTEMIC LUPUS ERYTHEMATOSUS.
  • Outcome of patients with lupus nephritis under long-term immunonephrological care
  • ‘The feeling of not being entitled to something’: fertility, pregnancy, and sexuality among women with systemic lupus erythematosus in South Africa.
  • Age at diagnosis and health-related quality of life are associated with fatigue in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort.
  • Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus.
  • Systemic lupus erythematosus with hypothyroidism as the initial clinical manifestation: A case report.
  • Urinary biomarkers in lupus nephritis.
  • The First Case of an Infant with Familial A20 Haploinsufficiency in Korea.
  • Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn’s disease.
  • A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics.
  • Ruptured Mycotic Aneurysm of the Distal Circulation in a Patient with Mucormycosis Without Direct Skull Base Extension: Case Report.
  • Mechanisms of hypertension in autoimmune rheumatic diseases.
  • Topic Modeling and User Network Analysis on Twitter during World Lupus Awareness Day.
  • Lupus nephritis in a transgender woman on cross-sex hormone therapy: a case for the role of oestrogen in systemic lupus erythematosus.
  • The Valued Life Activities Scale (VLAs): linguistic validation, cultural adaptation and psychometric testing in people with rheumatic and musculoskeletal diseases in the UK.
  • Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.
  • Lupus-associated protein losing enteropathy (LUPLE) complicated by a hypercoagulable state and successfully treated with belimumab.
  • Multiple coronary aneurysms and acute myocardial infarction in a female patient with rhupus: case report and literature review.
  • Hydroxychloroquine Alternatives for Chronic Disease: Response to a Growing Shortage Amid the Global COVID-19 Pandemic.
  • Effects of AS2819899, a novel selective PI3Kδ inhibitor, in a NZB/W F1 mouse lupus-like nephritis model.
  • Metabolic regulation of pathogenic autoimmunity: therapeutic targeting.
  • Neonatal lupus with left bundle branch block and cardiomyopathy: a case report.
  • Anti-nucleosome antibodies increase the risk of renal relapse in a prospective cohort of patients with clinically inactive systemic lupus erythematosus.
  • A Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythematosus
  • Spontaneous Superior Ophthalmic Vein Thrombosis in a Transgender Man with Systemic Lupus Erythematosus.
  • [New directions of pharmacotherapy of immune – inflammatory rheumatic diseases].
  • Bacteroides fragilis alleviates the symptoms of lupus nephritis via regulating CD1d and CD86 expressions in B cells.
  • Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
  • Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
  • Kidney outcomes for children with lupus nephritis.
  • Causes of hospitalization in Systemic Lupus Erythematosus: a narrative review.
  • Statins in COVID-19: is there any foundation?
  • MSCs-released TGFβ1 generate CD4+CD25+Foxp3+ in T-reg cells of human SLE PBMC.
  • Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis.
  • Outcomes of left ventricular assist device implantation in hypercoagulable patients.
  • EHR2Vec: Representation Learning of Medical Concepts From Temporal Patterns of Clinical Notes Based on Self-Attention Mechanism.
  • Autoimmune conditions and primary central nervous system lymphoma risk among older adults.
  • Genome Variation and Precision Medicine in Systemic Lupus Erythematosus.
  • Bilateral Acute Cardioembolic Limb Ischemia After Coronavirus Disease 2019 Pneumonia in a Lung Transplant Recipient: A Case Report.
  • Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis.
  • Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine.
  • Dystrophic Calcinosis Cutis in Systemic Lupus Erythematosus.
  • Hydroxychloroquine in rheumatic autoimmune disorders and beyond.
  • Rheumatic immune-related adverse events induced by immune checkpoint inhibitors.
  • Pulmonary embolism complicated the course of anti-N-methyl-D aspartate receptor encephalitis in a pediatric intensive care unit setting: A case report.
  • Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients.
  • Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: a case report.
  • Effectiveness of Bailing capsules in the treatment of lupus nephritis: A meta‑analysis.
  • Unexpected macrophage activation syndrome in a healthy young woman: a case report.
  • Centrally Acting ACE Inhibition in SLE
  • Comparison of complete renal response and mortality in early- and late-onset lupus nephritis: a multicenter retrospective study of a Japanese cohort.
  • Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial.
  • Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations.
  • Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants.
  • Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia.
  • Syk inhibitor attenuates inflammation in lupus mice from FcgRIIb deficiency but not in pristane induction: the influence of lupus pathogenesis on the therapeutic effect.
  • Severe bullous systemic lupus erythematosus successfully treated with low dose rituximab: a case report from sub-Saharan Africa.
  • Type I interferon antagonists in clinical development for lupus.
  • Anti-DNA antibodies cross-reactive with β2-glycoprotein I induce monocyte tissue factor through the TLR9 pathway.
  • Protective effect of dihydroartemisinin in inhibiting senescence of myeloid-derived suppressor cells from lupus mice via Nrf2/HO-1 pathway.
  • DNA Vaccination With Hsp70 Protects Against Systemic Lupus Erythematosus in (NZB × NZW)F1 Mice.
  • Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
  • Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases Part 2.
  • Bilateral patellar tendon rupture on lupus undergoing corticosteroids: a case report.
  • Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents.
  • A case of severe choroidal detachment in both eyes due to systemic lupus erythematosus.
  • Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
  • Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells.
  • What every nephrologist needs to know about hydroxychloroquine toxicity .
  • Comparison of treatment response and serious infection of tacrolimus, tacrolimus with mycophenolate mofetil, in comparison to cyclophosphamide as induction treatment for lupus nephritis .
  • Belimumab is Able to Induce a Significant Improvement of Joint Activity Status in Patients Diagnosed with Systemic Lupus Erythematosus: Results From a 12-Month Longitudinal Study.
  • Indwelling pleural catheter and successful autopleurodesis of refractory inflammatory lupus effusion.
  • Prevalence, outcome and prognostic factors of neuropsychiatric systemic lupus erythematosus: A real world single center study.
  • PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
  • [Atypical hydroxychloroquine maculopathy in an Asian woman with lupus].
  • Macrophage activation syndrome in a patient with systemic lupus erythematosus.
  • Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
  • Rapidly progressive glomerulonephritis after introduction of certolizumab pegol: a case report.
  • MicroRNA-30e-5p has an Integrated Role in the Regulation of the Innate Immune Response during Virus Infection and Systemic Lupus Erythematosus.
  • Clinical and histological significance of urinary CD11c+ macrophages in lupus nephritis.
  • Kidney Biopsy Findings in Patients with COVID-19.
  • Secondary Renal Neoplasia Following Chemotherapy or Radiation in Pediatric Patients.
  • Treatment of systemic lupus erythematosus.
  • Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus.
  • Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
  • Long Noncoding RNAs and Circular RNAs in Autoimmune Diseases.
  • Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2.
  • Bronchoalveolar lavage fluid analysis and mortality risk in systemic lupus erythematosus patients with pneumonia and respiratory failure.
  • Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus.
  • Acquired Human Papilloma Virus Type 6-Associated Epidermodysplasia Verruciformis in a Patient With Systemic Lupus Erythematosus.
  • Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy.
  • A Japanese-American female with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis.
  • Stakeholder-Engaged Derivation of Patient-Informed Value Elements.
  • Outcome of biopsy-proven lupus nephritis with low glomerular filtration rate at presentation.
  • Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan.
  • Response to: ‘Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India’ by Goyal et al.
  • Acquired Haemophilia A: An Intriguing Disease.
  • Autophagy and Autoimmune Diseases.
  • A case of Wong-type dermatomyositis treated with rituximab and IVIG.
  • Chronic Corticosteroid Use as a Risk Factor for Perioperative Complications in Patients Undergoing Total Joint Arthroplasty.
  • Cutaneous Complications Secondary to Haemostasis Abnormalities in COVID-19 Infection.
  • Immunological effects of vitamin D and their relations to autoimmunity.
  • Septic shock among patients with systemic lupus erythematosus: Short and long-term outcome. Analysis of a French nationwide database.
  • Deoxyribonucleases and Their Applications in Biomedicine.
  • Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate.
  • Macrophage activation syndrome in pediatrics: 10 years data from an Indian center.
  • Rhupus: a systematic literature review.
  • PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension.
  • Mitochondrial PCK2 Missense Variant in Shetland Sheepdogs with Paroxysmal Exercise-Induced Dyskinesia (PED).
  • Influence of glutathione S transferase A1 gene polymorphism (-69C > T, rs3957356) on intravenous cyclophosphamide efficacy and side effects: a case-control study in Egyptian patients with lupus nephritis.
  • One year in review 2020: systemic lupus erythematosus.
  • Hypertrophic cardiomyopathy in a lupus patient: a case of hydroxychloroquine cardiotoxicity.
  • Exacerbation of systemic lupus erythematosus in a patient with concomitant chronic plaque psoriasis treated with ustekinumab.
  • Androgen-Mediated Anti-inflammatory Cellular Processes as Therapeutic Targets in Lupus.
  • Tinea incognito: Clinical perspectives of a new imitator.
  • Rituximab for Autoimmune Encephalitis with Epilepsy.
  • Dietary oleuropein and its acyl derivative ameliorate inflammatory response in peritoneal macrophages from pristane-induced SLE mice via canonical and noncanonical NLRP3 inflammasomes pathway.
  • Hereditary C1 inhibitor deficiency associated with systemic lupus erythematosus.
  • Efficacy of Thalidomide in Discoid Lupus Erythematosus: Insights into the Molecular Mechanisms.
  • Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls.
  • The pathogenesis of cutaneous lupus erythematosus: The aberrant distribution and function of different cell types in skin lesions.
  • Case for diagnosis. Infiltrated areas on the trunk.
  • Curcumin attenuates autoimmunity and renal injury in an experimental model of systemic lupus erythematosus.
  • Continuation Rate, Safety and Efficacy of Hydroxychloroquine Treatment in a Retrospective Cohort of Systemic Lupus Erythematosus in a Japanese Municipal Hospital.
  • Natural products action on pathogenic cues in autoimmunity: Efficacy in systemic lupus erythematosus and rheumatoid arthritis as compared to classical treatments.
  • Durable benefit from immunotherapy and accompanied lupus erythematosus in pancreatic adenocarcinoma with DNA repair deficiency.
  • Coptisine Alleviates Pristane-Induced Lupus-Like Disease and Associated Kidney and Cardiovascular Complications in Mice.
  • Efficacy of high-intensity laser therapy on arthropathy of the hands in patients with systemic lupus erythematosus: a double-blinded, randomized controlled trial.
  • Autoimmune Conditions: Systemic Lupus Erythematosus.
  • CCCR Lupus Patient Navigator Program
  • [Effectiveness and safety of selective and non – selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti – Xa – activity range].
  • The role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases.
  • [Lupus 2020].
  • Hippocampal Atrophy in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations.
  • Drugs for Lupus While Breastfeeding.
  • Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab.
  • The multifaceted functional role of DNA methylation in immune-mediated rheumatic diseases.
  • Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment.
  • Dental Implant Therapy for Patients With Systemic Lupus Erythematosus
  • Chloroquine paradox may cause more damage than help fight COVID-19.
  • In vitro regulation of IL-6 and TGF-ß by mesenchymal stem cells in systemic lupus erythematosus patients.
  • Chloroquine, Hydroxychloroquine and Hearing Loss: A Study in Systemic Lupus Erythematosus Patients.
  • Per-protocol Repeat Kidney Biopsy in Incident Cases of Lupus Nephritis
  • Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results.
  • [JAK inhibitors: Perspectives in internal medicine].
  • Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice.
  • Advances In Drug Therapy For Systemic Lupus Erythematosus.
  • Systemic Lupus Erythematosus: Clinical Updates in Women’s Health Care Primary and Preventive Care Review.
  • Lupus, Silica, and Dietary Omega-3 Fatty Acid Interventions.
  • Podocytopathy as ‘stand-alone’ involvement in systemic lupus erythematosus: a case report.
  • Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus.
  • Dysregulation of Lipid Metabolism in Macrophages Is Responsible for Severe Endotoxin Tolerance in FcgRIIB-Deficient Lupus Mice.
  • Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?
  • A highly potent lymphatic system-targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus.
  • Sequential Belimumab and T-cell Based Therapy in SLE
  • Potential and prognostic factor for belimumab-free remission in patients with systemic lupus erythematosus: a single-center retrospective analysis.
  • Anti-IL-12/23 p40 antibody attenuates chronic graft-versus-host disease with lupus nephritis via inhibiting Tfh cell in mice.
  • Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity.
  • Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis.
  • Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus.
  • Human gingiva-derived mesenchymal stem cells are therapeutic in lupus nephritis through targeting of CD39-CD73 signaling pathway.
  • Celastrol Ameliorates Autoimmune Disorders in Trex1-deficient Mice.
  • Review: transcriptome and trans-omics analysis of systemic lupus erythematosus.
  • Photodynamic therapy combined with surgical management of extensive anogenital condylomatosis in a patient with systemic lupus erythematosus.
  • Visual recovery and vascular reperfusion after vaso-occlusive retinopathy from anti-phospholipid syndrome associated with systemic lupus erythematosus.
  • Feeding lactobacilli impacts lupus progression in (NZBxNZW)F1 lupus-prone mice by enhancing immunoregulation.
  • Proteomic analysis in lupus mice identifies Coronin-1A as a potential biomarker for lupus nephritis.
  • Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study.
  • Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases.
  • Treatment with Gonadotropin Releasing Hormone Agonists in Systemic Lupus Erythematosus Patients Receiving Cyclophosphamide: A Long-term Follow-up Study.
  • Effects of platelet and phospholipids on clot formation activated by a small amount of tissue factor.
  • Model informed dosing of Hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and Gaps.
  • O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus
  • Lupus enteritis as the sole presenting feature of systemic lupus erythematosus: case report and review of the literature.
  • Biologics in Sjögren’s syndrome.
  • Macrophage activation syndrome as a complication of dermatomyositis: A case report.
  • Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes.
  • A diagnostic solution for haemostasis laboratories for patients taking direct oral anticoagulants using DOAC-Remove.
  • New Frontiers: ARID3a in SLE.
  • Pregnancy and Systemic Lupus Erythematosus.
  • Contraception and preconception counseling in women with autoimmune disease.
  • Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
  • Clinical characteristics and long-term outcomes of Libman-Sacks endocarditis in patients with systemic lupus erythematosus.
  • Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center.
  • A Case of Non-tuberculosis Mycobacterium Tenosynovitis with Rice Bodies in a Patient with Systemic Lupus Erythematosus.
  • [Successful early treatment with acyclovir and corticosteroids for acute myelitis associated with zoster sine herpete: a case report].
  • C1q A08 Is a Half-Cryptic Epitope of Anti-C1q A08 Antibodies in Lupus Nephritis and Important for the Activation of Complement Classical Pathway.
  • HMGB1 in Systemic Lupus Erythematosus.
  • Clinical Efficacy of Routinely Administered Belimumab on Proteinuria and Neuropsychiatric Lupus.
  • Case 279: Central-Variant Posterior Reversible Encephalopathy Syndrome.
  • Seventy years after Hench’s Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus.
  • Population pharmacokinetics of mycophenolic acid in Mexican patients with lupus nephritis.
  • Efficacy of the Combination of Metformin and CTLA4Ig in the (NZB × NZW)F1 Mouse Model of Lupus Nephritis.
  • Cutaneous lupus erythematosus: factors related to cutaneous activity and damage in a cohort of 260 patients from A Coruña, Spain.
  • Testing for antiphospholipid antibodies: Advances and best practices.
  • The effect of DOACs on laboratory tests and their removal by activated carbon to limit interference in functional assays.
  • Healthy Lifestyle Intervention in Patients With Systemic Lupus Erythematosus: The Living Well With Lupus Study
  • A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)
  • Use of Antimalarial Agents is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus.
  • Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.
  • Therapeutic effects of a novel BAFF blocker on arthritis.
  • Endoscopic Z-plasty for Treatment of Supraglottic Stenosis: Experience on Nine Patients.
  • Monoclonal antibody therapy that targets phospholipid-binding protein delays lupus activity in MRL/lpr mice.
  • A Highly Sensitive Sandwich ELISA to Detect CSF Progranulin: A Potential Biomarker for CNS Disorders.
  • Role of IRF8 in immune cells functions, protection against infections, and susceptibility to inflammatory diseases.
  • SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
  • Initial Presentation and Progression of Secondary Osteonecrosis of the Knee.
  • Inflammasomes in Common Immune-Related Skin Diseases.
  • T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus.
  • Renal disorders in rheumatologic diseases: the spectrum is changing (Part 1: connective tissue diseases).
  • [Eculizumab as rescue therapy for lupus nephritis-related thrombotic microangiopathy].
  • The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States.
  • Comparison between2 Drugs in Lupus Nephritis
  • The role of IL-17 in systemic lupus erythematosus and its potential as a therapeutic target.
  • Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosus.
  • Metabolic syndrome and systemic lupus erythematosus: the connection.
  • Intracerebroventricular administration of lupus serum induces microglia activation and leukocyte adhesion in the cerebromicrovasculature of mice.
  • Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?
  • Cancer development and mortality differences in patients with glomerulonephritis after renal biopsy: a single center retrospective cohort study.
  • Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose.
  • ADRENAL INSUFFICIENCY SECONDARY TO BILATERAL ADRENAL HEMORRHAGE ASSOCIATED WITH ANTIPHOSPHOLIPID SYNDROME.
  • Effect of indole-3-carbinol on transcriptional profiling of wound-healing genes in macrophages of systemic lupus erythematosus patients: an RNA sequencing assay.
  • Aortitis in the setting of catastrophic antiphospholipid syndrome in a patient with systemic lupus erythematosus.
  • Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases.
  • Successful use of plasma exchange in fulminant lupus myocarditis coexisting with pneumonia: A case report.
  • COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination.
  • Acquired FXIII inhibitor: Patient characteristics and treatment outcome, a case series in Taiwan.
  • Response to: ‘Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak’ by Holubar et al.
  • Prevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosus.
  • Anti-TNF-induced lupus in patients with inflammatory bowel disease.
  • A Case with Purine Nucleoside Phosphorylase Deficiency Suffering from Late-Onset Systemic Lupus Erythematosus and Lymphoma.
  • Heat-Killed Lactobacillus reuteri GMNL-263 Inhibits Systemic Lupus Erythematosus-Induced Cardiomyopathy in NZB/W F1 Mice.
  • Extranasal extranodal NK/T-cell lymphoma associated with systemic lupus erythematosus.
  • Cardiogenic shock as the initial manifestation of systemic lupus erythematosus.
  • Accrual of atherosclerotic vascular events in a multicentre inception SLE cohort.
  • IFNβ signaling inhibits osteogenesis in human SLE bone marrow.
  • Serum exosomal hsa-miR-135b-5p serves as a potential diagnostic biomarker in steroid-induced osteonecrosis of femoral head.
  • The Effects of Alternate-Day Corticosteroids in Autoimmune Disease Patients.
  • A Case of Systemic Lupus Erythematosus/Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome with Dissociated Pathological and Immunological Findings.
  • Severe Pulmonary Hypertension as Initial Presentation of SLE: A Case Report and Literature Review.
  • Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?
  • Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study.
  • CD8+CD103+ iTregs Inhibit Chronic Graft-versus-Host Disease with Lupus Nephritis by the Increased Expression of CD39.
  • Renal microvascular lesions in lupus nephritis.
  • Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).
  • Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus.
  • Malignant Catatonia as the Presenting Manifestation of Systemic Lupus Erythematosus.
  • Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation.
  • Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.
  • Ezh2-mediated epigenetic modification is required for allogeneic T cell-induced lupus disease.
  • Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis.
  • TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune disorders of B cells in vitro.
  • An Update on the Diagnosis and Management of Lupus Nephritis.
  • Therapeutic peptides for the treatment of systemic lupus erythematosus: a place in therapy.
  • COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma.
  • Fatigue in adults with primary antiphospholipid syndrome: findings from a mixed-methods study.
  • The altered metabolism profile in pathogenesis of idiopathic inflammatory myopathies.
  • TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner.
  • Secondary vasculitis – omitted manifestation of many diseases.
  • Clinical and histopathological features and short-term outcomes of lupus nephritis: a prospective study of 100 Egyptian patients.
  • A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
  • Drug metabolising enzyme polymorphisms and chemotherapy-related ovarian failure in young breast cancer survivors.
  • Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients.
  • Fate of full-house immunofluorescence staining in renal allograft: A case report.
  • Rituximab use as induction therapy for lupus nephritis: a systematic review.
  • Ocular flare-up in patients with systemic lupus erythematosus following discontinuation of hydroxychloroquine.
  • Association of explanatory histological findings and urinary protein and serum creatinine levels at renal biopsy in lupus nephritis: a cross-sectional study.
  • Herbal medication triggering lupus nephritis – a case report.
  • Rheumatologic Disorders and the Nervous System.
  • Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New.
  • Pulmonary Hemosiderosis in a Child With Systemic Lupus Erythematosus: A Rare Presentation.
  • Streptococcus equi subsp. equi meningitis, septicemia and subdural empyema in a child.
  • The Search for a Uniformly Effective Treatment in Patients With Lupus Miliaris Disseminatus Faciei.
  • Could severe COVID-19 be considered a complementopathy?
  • Scarring alopecia in chronic cutaneous lupus erythematosus with neutrophils: A new scenario with therapeutic connotations.
  • Risk of Non-Melanoma Skin Cancer in Connective Tissue Disease and The Impact of Immunosuppressive Therapy.
  • Successful Treatment of Painful Cutaneous Vasculopathy With Rivaroxaban in a Patient With Systemic Lupus Erythematosus.
  • PROM Collected Via a WebApp Versus a Touch Screen Solution Among Patients With SLE
  • Safety and tolerability of sifalimumab, an anti-interferon-α monoclonal antibody, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study.
  • Safety and tolerability of anifrolumab, a monoclonal antibody targeting type I interferon receptor, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study.
  • Juvenile systemic lupus erythematosus presenting as pancarditis.
  • Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study.
  • Indeterminate cell histiocytosis in a patient with systemic lupus erythematosus and antiphospholipid antibody syndrome: an unusual association.
  • Recovery of renal function in patients with lupus nephritis and reduced renal function: the beneficial effect of hydroxychloroquine.
  • Which is the best SLE activity index for clinical trials?
  • Measurement of hydroxychloroquine in blood from SLE patients using LC-HRMS-evaluation of whole blood, plasma, and serum as sample matrices.
  • Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.
  • Response to: ‘Patients with lupus with COVID-19: University of Michigan experience’ by Wallace et al.
  • Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: ‘Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’ by Carbillon et al.
  • A Sensitive and Optimized HPLC-FLD Method for the Simultaneous Quantification of Hydroxychloroquine and Its Two Metabolites in Blood of Systemic Lupus Erythematosus Patients.
  • Simultaneous Bullous Pemphigoid and Vitiligo Associated with Adalimumab Therapy in a Patient with Psoriasis Vulgaris.
  • The Curious Case of an Elusive Solitary Plaque.
  • Systemic lupus erythematosus and risk of infection.
  • Failure of upregulation of the cold shock Y-box protein-1 in effector T-cells of systemic lupus erythematosus patients averts cell survival.
  • Correspondence regarding research letter to the editor by Mathian et al, ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’.
  • Response to: Correspondence regarding research letter to the editor by Mathian et al, ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine” by Nikpour et al.
  • Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus.
  • Health service utilization among African American women living with systemic lupus erythematosus: perceived impacts of a self-management intervention.
  • IL-12 and IL-23/Th17 axis in systemic lupus erythematosus.
  • circRNA-miRNA-mRNA regulatory network in human lung cancer: an update.
  • High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus.
  • Discoid Lupus Erythematosus Lesions Associated with Systemic Fluorouracil Agents: A Case Report and Review.
  • Downregulated miR‑29a promotes B cell overactivation by upregulating Crk‑like protein in systemic lupus erythematosus.
  • Meta-analysis on the efficacy and safety of immunoadsorption for systemic lupus erythematosus among Chinese population.
  • Case report: nosocomial fungemia caused by Candida diddensiae.
  • Urinary balantidiasis in a patient with systemic lupus erythematosus and lupus nephritis: a case report.
  • In Vivo Suppression of Autophagy via Lentiviral shRNA Targeting Atg5 Improves Lupus-Like Syndrome.
  • Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up.
  • STING palmitoylation as a therapeutic target.
  • Intestinal Spirochetosis Caused by Brachyspira pilosicoli in a Systemic Lupus Erythematosus Patient.
  • Prepregnancy Endocrine, Autoimmune Disorders and the Risks of Gestational Hypertension-Preeclampsia in Primiparas: A Nationwide Population-Based Study in Taiwan.
  • Lactobacillus fermentum CECT5716 prevents renal damage in the NZBWF1 mouse model of systemic lupus erythematosus.
  • Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
  • Diversity of neuropsychiatric manifestations in systemic lupus erythematosus.
  • PD-1 immunobiology in systemic lupus erythematosus.
  • Autophagy and immunological aberrations in systemic lupus erythematosus.
  • Single-nucleotide polymorphisms influence the promoter activities of systemic lupus erythematosus-associated genes.
  • Comparison of safety, efficacy and cost between oral pulse cyclophosphamide versus intravenous cyclophosphamide pulse therapy in severe systemic lupus erythematosus.
  • Hsp70 Gene Polymorphisms Are Associated With Disease Susceptibility and HRQOL Improvement in Chinese Han Population With Systemic Lupus Erythematosus.
  • A case of severe flare reaction observed in HLA B27 associated acute anterior uveitis.
  • Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy.
  • Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis.
  • Care Coordination Approaches to Learning Lupus Self-management
  • Genetic heterogeneity of pediatric systemic lupus erythematosus with lymphoproliferation.
  • Modulation of iron homeostasis with hepcidin ameliorates spontaneous murine lupus nephritis.
  • Management of Lupus Nephritis in Children.
  • Epigenetic Methods and Twin Studies.
  • Biocompatible nanovesicular drug delivery systems with targeting potential for autoimmune diseases.
  • Autoreactive B-lymphocytes in SLE and RA patients: Isolation and characterisation using extractable nuclear and citrullinated antigens bound to immunobeads.
  • Rituximab-associated hypogammaglobulinaemia in ANCA-associated vasculitis and connective tissue diseases: a longitudinal observational study.
  • Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case-control study with hydroxychloroquine blood-level analysis.
  • The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases
  • Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
  • Analysis of clinical and laboratory characteristics and pathology of lupus nephritis-based on 710 renal biopsies in China.
  • Clusters in Pediatric Rheumatic Diseases.
  • Analysis of Immunosuppressant Drugs in Whole Blood by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
  • Comprehensive bioinformatics analysis of mRNA expression profiles and identification of a miRNA-mRNA network associated with lupus nephritis.
  • Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
  • Adherence to hydroxychloroquine in patients with systemic lupus: contrasting results and weak correlation between assessment tools.
  • Therapeutic Impact of Statins on the Lipid Profile and Cardiovascular Risk in Patients With Systemic Lupus Erythematosus: Systematic Review of the Literature and a Meta-analysis.
  • Vasculitis Mimicking Pseudo Erysipelas in Systemic Lupus Erythematosus.
  • Identifying a response for the systemic lupus erythematosus disease activity glucocorticoid index (SLEDAI-2KG).
  • Autoimmune diseases and pregnancy.
  • Impact of COVID-19 pandemic on SLE: beyond the risk of infection.
  • Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus.
  • Glomerulonephritis Histopathological Pattern Change.
  • Systemic lupus erythematosus and glycation process.
  • Spontaneous bleeding in systemic lupus erythematosus: Endovascular treatment of two rare cases.
  • Benlysta-Loaded Sodium Alginate Hydrogel and Its Selective Functions in Promoting Skin Cell Growth and Inhibiting Inflammation.
  • Time to progression from discoid lupus erythematosus to systemic lupus erythematosus: a retrospective cohort study.
  • Nailfold microvascular changes in patients with systemic lupus erythematosus and their associative factors.
  • Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
  • Lupus cystitis: unusual cause of renal failure in systemic lupus erythematosus.
  • Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.
  • Lupus Erythematosus Tumidus with Pseudolymphomatous Infiltrates: A Case Report.
  • Naringenin mitigates autoimmune features in lupus-prone mice by modulation of T-cell subsets and cytokines profile.
  • Radix Paeoniae Rubra Ameliorates Lupus Nephritis in Lupus-Like Symptoms of Mrl Mice by Reducingintercellular Cell Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1, and Platelet Endothelial Cell Adhesion Molecule-1expression.
  • Rituximab or cyclosporin in refractory immune thrombocytopenia secondary to connective tissue diseases: a real-world observational retrospective study.
  • Increased prevalence of Lupus Co-morbidity in Patients with Psoriatic Arthritis: A Population-Based Case-Controlled Study.
  • Prophylactic effect of resveratrol and piperine on pristane-induced murine model of lupus-like disease.
  • Interindividual Variability in Lymphocyte Stimulation and Transcriptomic Response Predicts Mycophenolic Acid Sensitivity in Healthy Volunteers.
  • An overlap syndrome involving systemic lupus erythematosus and autoimmune hepatitis in a patient receiving a living-donor liver transplantation.
  • Glottic adhesion and stenosis in a patient with systemic lupus erythematosus.
  • Activation of the alternative complement pathway predicts renal outcome in patients with lupus nephritis.
  • Prevalence and risk factors of herpes zoster infection in patients with biopsy proven lupus nephritis undergoing immunosuppressive therapies.
  • Regulation of microRNA in systemic lupus erythematosus: the role of miR-21 and miR-210.
  • Lack of Uptake of Prophylactic Human Papilloma Virus Vaccine Among Women With Systemic Lupus Erythematosus Seen at a Regional Medical Center.
  • Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors.
  • MicroRNAs in Systemic Lupus Erythematosus: a Perspective on the Path from Biological Discoveries to Clinical Practice.
  • Comorbidities of antiphospholipid syndrome and systemic lupus erythematosus in children.
  • Quality of English-language videos on YouTube as a source of information on systemic lupus erythematosus.
  • Infection-related hospitalization after intensive immunosuppressive therapy among lupus nephritis and ANCA glomerulonephritis patients.
  • Listeria monocytogenes meningoencephalitis in a patient with Systemic Lupus Erythematosus.
  • Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2/HO-1 in myeloid-derived suppressor cells.
  • COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
  • Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial.
  • An Update on the Pathogenesis of Skin Damage in Lupus.
  • Rationale for and clinical development of anti-fractalkine antibody in rheumatic diseases.
  • SLE Vasculitis In Egyptian Patients
  • Keeping lupus patients on hydroxychloroquine during the COVID-19 pandemic.
  • Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials.
  • [Bentall Procedure for Annuloaortic Ectasia in a Patient with Systemic Lupus Erythematosus;Report of a Case].
  • Increased Expression of EZH2 Is Mediated by Higher Glycolysis and mTORC1 Activation in Lupus CD4+ T Cells.
  • The Comparison of Nailfold Capillaroscopy between Juvenile Systemic Lupus Erythematosus and Healthy Controls: Correlation with Laboratory and Clinical Parameters.
  • Integrated urine proteomics and renal single-cell genomics identify an interferon-γ response gradient in lupus nephritis.
  • Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis.
  • Multifocal mutilating lupus vulgaris leading to cosmetic disfigurement in an immunocompetent female.
  • Perplexing Pruritic Plaques and Pancytopenia: Subacute Cutaneous Lupus.
  • Does Systemic Lupus Erythematosus Increase the Risk of Procedure-Related Complication in Endovascular Treatment of Intracranial Aneurysm?
  • The Utility of Rise in Red Cell Distribution Width in Determining the Risk of Renal Relapse in Lupus Nephritis.
  • A novel long-acting azathioprine polyhydroxyalkanoate nanoparticle enhances treatment efficacy for systemic lupus erythematosus with reduced side effects.
  • Anti-Complement Factor H Autoantibodies May Be Protective in Lupus Nephritis.
  • Management of Fatigue in Rheumatoid Arthritis.
  • Chilblains in children in the setting of COVID-19 pandemic.
  • Effect of early eradication therapy on systemic lupus erythematosus risk in patients with Helicobacter pylori infection: a nationwide population-based cohort study.
  • Hydrogen peroxide and disease: towards a unified system of pathogenesis and therapeutics.
  • Correction: First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study.
  • Tumid Lupus Erythematosus and Systemic Lupus Erythematosus: A Report on Their Rare Coexistence.
  • Clinical and epidemiologic characterization of patients with systemic lupus erythematosus admitted to an intensive care unit in Colombia.
  • Digital dry gangrene as a primary manifestation of systemic lupus erythematosus.
  • THE HISTORY OF LUPUS THROUGHOUT THE AGES.
  • Difference in thrombotic microangiopathy (TMA) between concurrently and previously diagnosed SLE.
  • A case of complete atrioventricular block in secondary hemophagocytic syndrome/hemophagocytic lymphohistiocytosis recovered by plasma exchange and cytokine absorbing therapy with AN69ST continuous hemodiafiltration.
  • Clinical practice guidelines and recommendations for the management of patients with systemic lupus erythematosus: a critical comparison.
  • A Study of Guselkumab in Participants With Active Lupus Nephritis
  • Abdominal pain, nausea, vomiting, and ascites in a 14-year-old girl with systemic lupus erythematosus: Answers.
  • Relationship of Excess Weight with Clinical Activity and Dietary Intake Deficiencies in Systemic Lupus Erythematosus Patients.
  • The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis.
  • Autoimmunity and organ damage in systemic lupus erythematosus.
  • High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
  • Oral manifestations associated with antimalarial therapy in patients with systemic lupus erythematosus.
  • Cosmetic Treatment in Patients with Autoimmune Connective Tissue Diseases. Part II. Best Practices for Patients with Lupus Erythematosus.
  • KEGG-expressed genes and pathways in triple negative breast cancer: Protocol for a systematic review and data mining.
  • Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation.
  • Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
  • Is serum uric acid a predictor of long-term renal outcome in lupus nephritis?
  • Prevalence and influential factors of thrombocytopaenia in systemic lupus erythematosus patients: a retrospective analysis of 3140 cases in a Chinese population.
  • Large-scale mortality gap between SLE and control population is associated with increased infection-related mortality in lupus.
  • Treat to Target in Systemic Lupus Erythematosus.
  • Lupus érythémateux systémique.
  • Thoughts on COVID-19 and autoimmune diseases.
  • A novel TRAF3IP2 variant causing familial scarring alopecia with mixed features of discoid lupus erythematosus and folliculitis decalvans.
  • Potential Molecular Mechanisms of Zhibai Dihuang Wan in Systemic Lupus Erythematosus Based on Network Biology.
  • Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis.
  • Pulmonary and Bronchiolar Involvement in Sjogren’s Syndrome.
  • The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.
  • Autophagy in Immune-Related Renal Disease.
  • Early and Short-Term Interventions in the Gut Microbiota Affects Lupus Severity, Progression, and Treatment in MRL/lpr Mice.
  • Influence of air pollution on renal activity in patients with childhood-onset systemic lupus erythematosus.
  • Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus.
  • Telemedicine for Follow-up of Systemic Lupus Erythematosus
  • Protective Effects of Probiotic Consumption in Cardiovascular Disease in Systemic Lupus Erythematosus.
  • Feasibility and acceptability of an innovative adherence intervention for young adults with childhood-onset systemic Lupus Erythematosus.
  • [Bone marrow serous degeneration complicating acute leukemia].
  • Conventional versus Rapid Glucocorticoid Tapering in Severe Systemic Lupus Erythematosus Patients: A Non-Blind, Randomized Controlled Trial.
  • Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA.
  • Loss of mitochondrial ClpP, Lonp1, and Tfam triggers transcriptional induction of Rnf213, a susceptibility factor for moyamoya disease.
  • Cutaneous polyautoimmunity in two unrelated dogs: pemphigus foliaceus and generalized discoid lupus erythematosus.
  • Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice.
  • Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus.
  • Uncovering Molecular Targets for Regenerative Therapy in Degenerative Disc Disease: Do Small Leucine-Rich Proteoglycans hold the Key?
  • Balancing immunosuppression and infection: recurrent enterovirus encephalitis in SLE.
  • [Hazard of acquired long QT syndrome during coronavirus pandemic. Focus on hydroxychloroquine].
  • Neurodegeneration in systemic lupus erythematosus: layer by layer retinal study using optical coherence tomography.
  • Clinical Features of Type B Insulin Resistance in Japanese Patients: Case Report and Survey-Based Case Series Study.
  • Frequencies and predictors of the Lupus Low Disease Activity State and remission in treatment-naïve patients with systemic lupus erythematosus.
  • Topical delivery of siRNA into skin using ionic liquids.
  • [A rare cause of impaired general condition: Muscular and cardiac toxicity of antimalarials].
  • A clinical population pharmacokinetic/pharmacodynamic model for BIIB059, a monoclonal antibody for the treatment of systemic and cutaneous lupus erythematosus.
  • Mechanistic Paradigms of Natural Plant Metabolites as Remedial Candidates for Systemic Lupus Erythromatosus.
  • A Spectrum of Skin Disease: How Staphylococcus aureus Colonization, Barrier Dysfunction, and Cytokines Shape the Skin.
  • Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.
  • Rapid induction of clinical remission by immunoadsorption for refractory lupus retinopathy complicated with life-threatening neuropsychiatric lupus.
  • A Woman with Systemic Lupus Erythematosus and Odd Valvular Presentation: A Case Report.
  • Non-increased risk of thrombosis by steroid pulse therapy in patients with lupus nephritis from the Japanese health insurance database.
  • Individual Patient Exposure and Response in Pediatric Lupus
  • MiR-153-3p induces immune dysregulation by inhibiting PELI1 expression in umbilical cord-derived mesenchymal stem cells in patients with systemic lupus erythematosus.
  • Retroviruses in the pathogenesis of systemic lupus erythematosus: Are they potential therapeutic targets?
  • Psoriasis and systemic lupus erythematosus in children – literature review based on case report.
  • Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus.
  • [Mesenchymal stem cell treatment in autoimmune diseases].
  • Development and Study of Semi-Solid Preparations Containing the Model Substance Corticotropin (ACTH): Convenience Application in Neurodegenerative Diseases.
  • Non-bullous neutrophilic lupus erythematosus-Muted bullous disease?
  • Double Negative B Cell Is Associated With Renal Impairment in Systemic Lupus Erythematosus and Acts as a Marker for Nephritis Remission.
  • A Validation of the 2018 Revision of International Society of Nephrology/Renal Pathology Society Classification for Lupus Nephritis: A Cohort Study from China.
  • MALAT1 is involved in type I IFNs-mediated systemic lupus erythematosus by up-regulating OAS2, OAS3, and OASL.
  • Maternal and fetal complications associated with systemic lupus erythematosus: An updated meta-analysis of the most recent studies (2017-2019).
  • Severe vaso-occlusive lupus retinopathy in the early stage of a pediatric patient with systemic lupus erythematosus: a case report.
  • Assessment of lung glucose uptake in patients with systemic lupus erythematosus pulmonary arterial hypertension: a quantitative FDG-PET imaging study.
  • Profile of common inflammatory markers in treatment-naïve patients with systemic rheumatic diseases.
  • StatPearls
  • StatPearls
  • StatPearls
  • Palisaded Neutrophilic and Granulomatous Dermatitis in a Patient with Granulomatosis with Polyangiitis.
  • How can we define low disease activity in systemic lupus erythematosus?
  • Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs.
  • Potential therapeutic applications of exosomes in different autoimmune diseases.
  • Hydroxychloroquine may reduce risk of Pneumocystis pneumonia in lupus patients: a Nationwide, population-based case-control study.
  • The approach to precision medicine for the treatment of psoriatic arthritis.
  • Characterization of IL-19, -20, and -24 in acute and chronic kidney diseases reveals a pro-fibrotic role of IL-24.
  • [An autopsied case of severe varicella zoster virus-associated encephalomyelitis under immunosuppressant therapy].
  • Non-Coding RNAs in CD4+ T Cells: New Insights Into the Pathogenesis of Systemic Lupus Erythematosus.
  • [New treatments for systemic lupus erythematosus].
  • Refractory secondary thrombotic microangiopathy with kidney injury associated with systemic lupus erythematosus in a pediatric patient.
  • Antiphospholipid syndrome presenting as treatment resistant bipolar disorder and thrombocytopenia in a young male.
  • Nuclear magnetic resonance-based targeted profiling of urinary acetate and citrate following cyclophosphamide therapy in patients with lupus nephritis.
  • Siglec genes confer resistance to systemic lupus erythematosus in humans and mice.
  • Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis.
  • [Lupus and thrombophilia : Antiphospholipid syndrome].
  • Does SLE widen or narrow race/ethnic disparities in the risk of five co-morbid conditions? Evidence from a community-based outpatient care system.
  • Changes in quality of life in relation to disease activity in systemic lupus erythematosus: post-hoc analysis of the BLISS-52 Trial.
  • Predictors of predominant Lupus Low Disease Activity State (LLDAS-50).
  • The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus.
  • The lupus patient traveller: a guide to the rheumatologist.
  • Hydroxychloroquine and covid-19.
  • Using the mouse to model human diseases: Cognitive impairment in SLE.
  • High salt diet accelerates the progression of murine lupus through dendritic cells via the p38 MAPK and STAT1 signaling pathways.
  • The role of follicular T helper cells in the onset and treatment of type 1 diabetes.
  • Palliative and end-of-life care in rheumatology: High symptom prevalence and unmet needs.
  • Predicting flares in patients with stable systemic lupus erythematosus.
  • Causes and Factors Associated with Frequent Hospitalization in Chinese Patients with Systemic Lupus Erythematosus: An Ambispective Cohort Study.
  • Association of systemic lupus erythematosus disease activity index score with clinical and laboratory parameters in pediatric onset systemic lupus erythematosus.
  • Association of Autoimmune Hashimoto’s Thyroiditis with Systemic Lupus Erythematosis.
  • Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19.
  • Long-lasting successful treatment of a donkey with cutaneous lupus erythematous with methotrexate.
  • Cognitive dysfunction in autoimmune rheumatic diseases.
  • Dramatic and Rapid Resolution of Both Psychosis and Neuroleptic-Related Catatonia With Zolpidem in a Patient With Systemic Lupus Erythematosus.
  • Lupus-Induced Vasculitis and Multiple Organ Dysfunction Syndrome as the First Presentation of Systemic Lupus Erythematosus (SLE) in Pregnancy.
  • High salt diet accelerates the progression of murine lupus through dendritic cells via the p38 MAPK and STAT1 signaling pathways.
  • Risk of Ocular Anomalies in Children Exposed In Utero to Antimalarials: A Systematic Literature Review.
  • CD8+CD103+ iTregs inhibit the progression of lupus nephritis by attenuating glomerular endothelial cell injury.
  • B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids.
  • The mysteries of rapidly destructive arthrosis of the hip joint: a systemic literature review.
  • CD4+CD28null T cells are expanded in moderately active systemic lupus erythematosus and secrete pro-inflammatory interferon gamma, depending on the Disease Activity Index.
  • Correlation Between Steroid Therapy and Lipid Profile in Systemic Lupus Erythematosus Patients.
  • Pattern of biopsy-proven renal disease in Sabah: A retrospective cross-sectional study over 3.5 years.
  • A review of fetal and neonatal consequences of maternal systemic lupus erythematosus.
  • Neutrophil Extracellular Traps (NETs) Take the Central Stage in Driving Autoimmune Responses.
  • Analysis of the receptor BCMA as a biomarker in systemic lupus erythematosus patients.
  • Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.
  • Mock Recruitment for the Study of Antimalarials in an Incomplete Lupus Erythematosus Trial.
  • Refractory lupus erythematosus tumidus responsive to tildrakizumab.
  • Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.
  • Total knee arthroplasty outcomes in lupus: a study using the US National Inpatient Sample.
  • An atypical presentation of subacute cutaneous lupus erythematous.
  • Placenta accrete after a frozen-thawed embryo transfer in a systemic lupus erythematosus patient treated with hydroxychloroquine.
  • Case of using mycophenolate in combination with steroids for concurrent macrophage activation syndrome and lupus flare.
  • Predictive factors of quality of life among systemic lupus erythematosus patients in Thailand: a web-based cross-sectional study.
  • Pigmented linear discoid lupus erythematosus following the lines of Blaschko: A retrospective study of a Chinese series.
  • Hypertensive disorders of pregnancy associated with adverse pregnant outcomes in patients with systemic lupus erythematosus: a multicenter retrospective study.
  • Acute respiratory involvement in Colombian patients with systemic lupus erythematosus undergoing chest computed tomography.
  • UV radiation exposure in welders: impact on the skin and eyes.
  • Subarachnoid Hemorrhage After Ischemic Stroke Associated with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
  • Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: Insights from renal ultrastructural findings.
  • Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
  • Retinoic Acid Exerts Disease Stage-Dependent Effects on Pristane-Induced Lupus.
  • Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders.
  • Intralesional Injection of Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Knee Secondary to Systemic Lupus Erythematosus: A Case Report.
  • Successful treatment of facial localized discoid lupus erythematosus with intralesional betamethasone: A report of three cases.
  • Primary central nervous system lymphoma in neuropsychiatric systemic lupus erythematosus: case-based review.
  • Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects.
  • Etiologies and Treatment Burden in Adult Patients with Pure Red Cell Aplasia: A Single-Center Experience and Review of Literature.
  • Peptide-Based Vaccination Therapy for Rheumatic Diseases.
  • The expression of XBP1s in B lymphocytes is critical for pristane-induced lupusnephritis in mice.
  • What are the latest clinical findings regarding the association of neurotoxic brain antibodies found in the cerebrospinal fluid in patients with autoimmune disorders?
  • Telehealth CBT for Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus
  • Cutaneous Lupus Erythematosus: Progress and Challenges.
  • Efficacy of a Physical Activity Counselling Program with Use of Wearable Tracker in People with Inflammatory Arthritis: A Randomized Controlled Trial.
  • Inflammatory and T Helper 17/ Regulatory T Cells Related Cytokines Balance in Cutaneous Lupus Erythematosus (CLE).
  • Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania.
  • Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus.
  • A case of lupus miliaris disseminatus faciei that was successfully treated with 595 nm pulsed-dye laser combined with drugs.
  • [Early diagnosis and treat-to-target to improve prognosis of systemic lupus erythematosus in China].
  • Response to: ‘Glucocorticoid withdrawal in lupus: to do or not to do?’ by Acharya.
  • Deployment o the Multidisciplinary Prospective Cohort Imminent
  • Drug-induced acute eosinophilic pneumonia due to hydroxychloroquine in a chilblain lupus patient.
  • Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study.
  • Effect of air pollution on hospital admissions for systemic lupus erythematosus in Bengbu, China: a time series study.
  • [New and Established Therapeutic Options for the Treatment of Systemic Lupus Erythematosus].
  • Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells.
  • Pharmacokinetics of flucytosine in a critically ill patient on continuous venovenous hemodiafiltration.
  • Safety management in treatment with antimalarials in rheumatology. Interdisciplinary recommendations on the basis of a systematic literature review.
  • [Pregnancy with lupus erythematosus-an update].
  • Anifrolumab in systemic lupus erythematosus: current knowledge and future considerations.
  • The basic and translational science year in review: Confucius in the era of Big Data.
  • Long-term safety and effectiveness of tacrolimus in lupus nephritis patients: 5- year interim post-marketing surveillance study in Japan (TRUST).
  • Advanced Chronic Kidney Disease in Lupus Nephritis: Is Dialysis Inevitable?
  • Drug-Induced Lupus, a One-time Hit or a Harbinger of Future Autoimmunity: A Case Report.
  • Protein spectrum changes in exosomes after therapeutic plasma exchange in patients with neuromyelitis optica.
  • Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody.
  • Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study.
  • Influence of the Period of Abstinence on Semen Quality in a Patient with Systemic Lupus Erythematosus: A Case Report and Review of the Literature.
  • [Treat to target in systemic lupus erythematosus].
  • Systemic lupus erythematosus in pregnancy: high risk, high reward.
  • Characteristics and risk factors of an emergency department visit in patients with systemic lupus erythematosus.
  • Myelofibrosis associated with systemic lupus erythematosus successfully treated with rituximab.
  • VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease.
  • A Mobile Learning Module to Support Interprofessional Knowledge Construction in the Health Professions.
  • A Flare-up of Systemic Lupus Erythematosus with Unusual Enteric Predominance.
  • Bradykinin 1 receptor blockade subdues systemic autoimmunity, renal inflammation, and blood pressure in murine lupus nephritis.
  • Nailfold capillaroscopy as a risk factor for pulmonary arterial hypertension in systemic lupus erythematosus patients.
  • Association of anti-nuclesome and anti C1q antibodies with lupus nephritis in an Egyptian cohort of patients with systemic lupus erythematosus.
  • Disease activity and thromboembolic events in women with systemic lupus erythematosus with and without anti-phospholipid syndrome: users of the 52-mg levonorgestrel-releasing intrauterine system.
  • Incidence of Cytomegalovirus Antigenemia in patients with autoimmune rheumatic diseases: a 3-year retrospective study.
  • The effect of lupus disease on the pregnant women and embryos: a retrospective study from 2010 to 2014.
  • JAK Inhibitors: Prospects in Connective Tissue Diseases.
  • Update on Lupus Nephritis: Core Curriculum 2020.
  • The αC helix of TIRAP holds therapeutic potential in TLR-mediated autoimmune diseases.
  • 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
  • Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritis.
  • Acute Myocardial Infarction Due to Antiphospholipid Syndrome – Case Report and Review of the Literature.
  • Traction screws to reduce a bilateral pedicle fracture of L5: a case report.
  • From Severe Herpes Zoster to Rare Suid Herpesvirus Encephalitis: A New Twist of the Varicellovirus Genus Infection in Patients with Kidney Diseases.
  • [Janus kinase inhibitors : State of the art in clinical use and future perspectives].
  • Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis.
  • Déjà Vu But New: Using T Cells to Deplete B Cells to Treat Lupus.
  • A Bayesian gene network reveals insight into the JAK-STAT pathway in systemic lupus erythematosus.
  • [Recommendations of diagnosis and treatment of primary Sjögren’s syndrome in China].
  • The Role of Calcium-Calcineurin-NFAT Signaling Pathway in Health and Autoimmune Diseases.
  • Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?
  • A new target for the treatment of inflammatory bowel disease: Interleukin-37.
  • Interferon-complement loop in transplant-associated thrombotic microangiopathy.
  • Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis
  • A case of lupus miliaris disseminatus faciei after allogeneic hematopoietic stem cell transplantation.
  • Discontinuation of therapy in lupus nephritis.
  • Contribution of mouse models in our understanding of lupus.
  • Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy.
  • MicroRNA-125a Loaded Polymeric Nanoparticles Alleviate Systemic Lupus Erythematosus by Restoring Effector/Regulatory T Cells Balance.
  • Dysbiosis of oral microbiota is associated with systemic lupus erythematosus.
  • Successful treatment of refractory lupus erythematosus profundus with the interleukin-6 antagonist tocilizumab: a case report.
  • DNA methylation plays an important role in immune thrombocytopenia.
  • Twelve-month outcome in juvenile proliferative lupus nephritis: results of the German registry study.
  • Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.
  • Chemokine-like factor-like MARVEL transmembrane domain-containing family in autoimmune diseases.
  • Deep Breathing Increases Heart Rate Variability in Patients With Rheumatoid Arthritis and Systematic Lupus Erythematosus.
  • The prevalence of insomnia and restless legs syndrome among Japanese outpatients with rheumatic disease: A cross-sectional study.
  • Systemic lupus erythematosus associated with thymoma: A fifteen-year observational study in France.
  • Relationship between remission, disease activity and patient-reported outcome measures in patients with recent-onset systemic lupus erythematosus.
  • Low frequency of flares during pregnancy and post-partum in stable lupus patients.
  • Comments on the article: “Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial”.
  • Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus.
  • Joint trajectories of disease activity, and physical and mental health-related quality of life in an inception lupus cohort.
  • Personalized therapy design for systemic lupus erythematosus based on the analysis of protein-protein interaction networks.
  • Clinical usefulness of serum levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio to rule out preeclampsia in women with new-onset lupus nephritis during pregnancy.
  • Acute myocardial infarction and transient elevated anticardiolipin antibody in a young adult with possible familial hypercholesterolemia: a case report : Anticardiolipin antibody and myocardial infarction.
  • Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6+B helper T cells in systemic lupus erythematosus.
  • Tubulointerstitial lesions converted into lupus nephritis.
  • Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management.
  • Management of urticarial vasculitis: A worldwide physician perspective.
  • Fatal Disseminated Aspergillosis in a Patient with Systemic Lupus Erythematosus.
  • The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLE.
  • LOX-1: A potential driver of cardiovascular risk in SLE patients.
  • [Polymorphism and differential diagnosis of neonatal lupus erythematosus].
  • A Case of Linear Cutaneous Lupus Erythematosus in a 55-Year-Old Woman.
  • Total pulmonary artery replacement with an Avalus-Gelweave conduit in a patient with giant pulmonary artery aneurysm with pulmonary regurgitation.
  • PEPITEM/Cadherin 15 Axis Inhibits T Lymphocyte Infiltration and Glomerulonephritis in a Mouse Model of Systemic Lupus Erythematosus.
  • Macrophage activation syndrome as an initial presentation of systemic lupus erythematosus with sensorineural hearing loss in a young male patient.
  • Pregnancy outcomes in women with rheumatic diseases: a real-world observational study in Japan.
  • Global public interest in systemic lupus erythematosus: an investigation based on internet search data.
  • Antiphospholipid antibodies in patients with lupus nephritis: clinical correlations and associations with long-term outcomes.
  • Implementation and dissemination of an African American popular opinion model to improve lupus awareness: an academic-community partnership.
  • Sexual function and reproduction can be impaired in men with rheumatic diseases: A systematic review.
  • Acute interstitial nephritis and drug-induced systemic lupus erythematosus due to chlorthalidone and amiodarone: A case report.
  • Hyperkalemia in type 4 renal tubular acidosis associated with systemic lupus erythematosus.
  • Delgocitinib: First Approval.
  • Anti-inflammation Effects of Sinomenine on Macrophages through Suppressing Activated TLR4/NF-κB Signaling Pathway.
  • [Targeted therapies for connective tissue diseases and vasculitis].
  • Sudden Cardiac Arrest as the First Manifestation in a Patient with Catastrophic Antiphospholipid Syndrome.
  • [A case of bullous systemic lupus erythematosus with sloughing esophagitis].
  • The Relationship between Erythrocyte Sedimentation Rate and Erythrocyte Sedimentation/Red Blood Cell Ratio and Disease Activity in Systemic Lupus Erythematosus.
  • Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis.
  • Mindfulness- Based Intervention for Systemic Lupus Erythematosus (SLE) Patients
  • A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)
  • Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies.
  • Metabolic Profiling Reveals an Abnormal Pattern of Serum Fatty Acids in MRL/lpr Mice Under Treatment With Prednisone.
  • Therapeutic potential of enhancer of zeste homolog 2 in autoimmune diseases.
  • Assessment of ovarian reserve by serum anti-Müllerian hormone in patients with systemic lupus erythematosus: a meta-analysis.
  • [Obstetrics complications of systemic lupus erythematosus and antiphospholipid syndrome: a multidisciplinary management].
  • Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus.
  • Rituximab effect in severe progressive connective tissue disease-related lung disease: preliminary data.
  • Abnormal expression of BAFF and its receptors in peripheral blood and skin lesions from systemic lupus erythematosus patients.
  • Inhibition of mTOR suppresses IFNα production and the STING pathway in monocytes from systemic lupus erythematosus patients.
  • The Evolving Role of Calcineurin Inhibitors in Treating Lupus Nephritis.
  • Newly Diagnosed Systemic Lupus Erythematosus: Atypical Presentation With Focal Seizures and Long-standing Lymphadenopathy.
  • Gangrene of All Digits and Toes Attributable to Systemic Lupus Erythematosus With Negative Antiphospholipid Antibodies.
  • Leukocytoclastic Vasculitis Concurrent With Bullous Systemic Lupus Erythematosus Manifesting Striking Wood-Grain and Wi-Fi Sign-like Purpuric Lesions.
  • Leveraging Google Trends to investigate the global public interest in rheumatoid arthritis.
  • Quality of life among female patients with systemic lupus erythematosus in remission.
  • Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent.
  • Serum uric acid is associated with damage in patients with systemic lupus erythematosus.
  • Prediction of prognosis and renal outcome in lupus nephritis.
  • Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study.
  • Neuromyelitis Optica Spectrum Disorder in a Patient With Systemic Lupus Erythematosus.
  • Hearing loss caused by discoid lupus erythematosus of the ear canal successfully treated with hydroxychloroquine.
  • [2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus].
  • [Clinical characteristics and risk factors of patients with systemic lupus erythematosus and cancer].
  • Dosage and Duration of Methylprednisolone Therapy Affect the Occurrence of Cushing Habitus in Patients with Systemic Lupus Erythematosus.
  • [The 476th case: skin rash, edema, thrombocytopenia and anemia].
  • Herpes Simplex Virus-2 Hepatitis: A Case Report and Review of the Literature.
  • Treatment pattern and medical cost of systemic lupus erythematosus patients in Japan: A retrospective claims database study.
  • Cocaine Use and Levamisole-Induced Vasculitis: A Multiple Case Study.
  • Curcumin Attenuates Both Acute and Chronic Immune Nephritis.
  • A case of recovery from aphasia following dose reduction of cefepime by bayesian prediction-based therapeutic drug monitoring.
  • Escaping the catch 22 of lupus anticoagulant testing.
  • P-selectin blockade ameliorates lupus nephritis in MRL/lpr mice through improving renal hypoxia and evaluation using BOLD-MRI.
  • Deep Neck Infection in Systemic Lupus Erythematosus Patients: Real-World Evidence.
  • Treatment of cutaneous lupus erythematosus: current approaches and future strategies.
  • Systemic Lupus Erythematosus from Lupus Enteritis.
  • Lupus anticoagulant remission after gluten-free diet in a coeliac pregnant woman.
  • Linear lupus panniculitis of the scalp with good response to thalidomide.
  • State-of-the-art treatment of systemic lupus erythematosus.
  • Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE).
  • Exposure to Ultraviolet Radiation in the Modulation of Human Diseases.
  • Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study.
  • Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.
  • Lupus nephritis complicated by cytomegalovirus colitis, aspergillosis and brain abscess.
  • B cells control lupus autoimmunity by inhibiting Th17 and promoting Th22 cells.
  • Systematic review and case report: Systemic lupus erythematosus with renal tubular acidosis.
  • Non-bacterial thrombotic endocarditis in the context of pulmonary adenocarcinoma: a case report.
  • Structural dynamics of inosine triphosphate pyrophosphatase (ITPA) protein and two clinically relevant mutants: molecular dynamics simulations.
  • Complete Remission of Hypertrophic Discoid Cutaneous Lupus Erythematosus After Treatment of Chronic Hepatitis C With Direct-Acting Antivirals.
  • A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
  • Prediction of fetal loss in Chinese pregnant patients with systemic lupus erythematosus: a retrospective cohort study.
  • Autoimmune Connective Tissue Diseases and the Risk of Rotator Cuff Repair Surgery: A Population-Based Retrospective Cohort Study.
  • The role of programed death-ligand 1 in renal diseases.
  • A case report of heart transplant for ischaemic cardiomyopathy from lupus coronary vasculitis.
  • Trends in Maternal and Fetal Outcomes Among Pregnant Women With Systemic Lupus Erythematosus in the United States: A Cross-sectional Analysis.
  • Management of maternal antiphospholipid syndrome.
  • Chemokines in rheumatic diseases: pathogenic role and therapeutic implications.
  • Association of Poverty Income Ratio with Physical Functioning in a Cohort of Patients with Systemic Lupus Erythematosus.
  • Subacute Cutaneous Lupus Erythematosus with Positive Anti-Ro Antibodies Following Palbociclib and Letrozole Treatment: A Case Report and Literature Review.
  • Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1.
  • Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the ‘Attikon’ cohort.
  • Induction therapy with rituximab for lupus nephritis due to prolidase deficiency.
  • Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study.
  • B cells targeting therapy in the management of systemic lupus erythematosus.
  • Treatment with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Dermatomyositis/Polymyositis.
  • Retrospective, single-center case series of neonatal lupus.
  • New therapies for systemic lupus erythematosus – past imperfect, future tense.
  • Pregnancy in Women With Lupus: We Have Come So Far and Have So Far to Go.
  • Absorption, distribution, metabolism, and excretion of cenerimod, a selective S1P1 receptor modulator in healthy subjects.
  • Value of heart rate recovery in female patients with pulmonary arterial hypertension due to systemic lupus erythematosus.
  • Antimalarial agents diminish while methotrexate, azathioprine and mycophenolic acid increase BAFF levels in systemic lupus erythematosus.
  • Is maxillary diastema an appropriate site for implantation in rats?
  • Cardiac Arrhythmias in Autoimmune Diseases.
  • Comprehensive analyses of long non-coding RNA expression profiles by RNA sequencing and exploration of their potency as biomarkers in psoriatic arthritis patients.
  • Circular RNAs hsa_circ_0000479 in peripheral blood mononuclear cells as novel biomarkers for systemic lupus erythematosus.
  • Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus.
  • Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus.
  • String of successful trials in SLE: have we cracked the code?
  • [Safety management of the treatment with antimalarial drugs in rheumatology. Interdisciplinary recommendations based on a systematic literature search].
  • Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.
  • Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus.
  • Gene-function studies in systemic lupus erythematosus.
  • A Novel System to Categorize the Symptoms of Systemic Lupus Erythematosus.
  • Systemic lupus erythematosus-associated neutrophilic dermatosis manifesting as an acneiform eruption and foot pain.
  • Postactivated B cells in systemic lupus erythematosus: update on translational aspects and therapeutic considerations.
  • Cutaneous mycobacterial co-infection in a patient with systemic lupus erythematosus.
  • Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus.
  • Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.
  • Chronic thrombotic microangiopathy secondary to antiphospholipid syndrome, presenting with severe hypertension and chronic renal impairment.
  • [Lupus enteritis. Report of one case].
  • Epigenetic Therapy as a Putative Molecular Target to Modulate B Cell Biology and Behavior in the Context of Immunological Disorders.
  • The continuous rediscovery and the benefit-risk ratio of thioguanine, a comprehensive review.
  • 2019 American College of Rheumatology Reproductive Health in Rheumatic and Musculoskeletal Diseases Guideline.
  • 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.
  • Opioid dispensation among systemic lupus erythematosus patients who persistently frequent the emergency department.
Back to top